| Product Code: ETC7554250 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India solid tumor drugs market import shipment demonstrated a steady growth trend with a CAGR of 3.0% from 2020 to 2024. The market experienced a notable acceleration in growth between 2023 and 2024, with a growth rate of 26.5%. Overall, the market expanded consistently, showing increasing momentum towards the end of the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Solid Tumor Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Solid Tumor Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Solid Tumor Drugs Market - Industry Life Cycle |
3.4 India Solid Tumor Drugs Market - Porter's Five Forces |
3.5 India Solid Tumor Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Solid Tumor Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Solid Tumor Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of solid tumors in India |
4.2.2 Growing awareness about early diagnosis and treatment of solid tumors |
4.2.3 Technological advancements in drug development for solid tumors |
4.3 Market Restraints |
4.3.1 High cost of solid tumor drugs |
4.3.2 Stringent regulatory requirements for drug approval in India |
4.3.3 Limited access to advanced treatment options in remote areas |
5 India Solid Tumor Drugs Market Trends |
6 India Solid Tumor Drugs Market, By Types |
6.1 India Solid Tumor Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Solid Tumor Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Solid Tumor Drugs Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.1.4 India Solid Tumor Drugs Market Revenues & Volume, By Biologics, 2021- 2031F |
6.1.5 India Solid Tumor Drugs Market Revenues & Volume, By Enzymes, 2021- 2031F |
6.1.6 India Solid Tumor Drugs Market Revenues & Volume, By Blood and Blood Components, 2021- 2031F |
6.1.7 India Solid Tumor Drugs Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.1.8 India Solid Tumor Drugs Market Revenues & Volume, By Recombinant Proteins, 2021- 2031F |
6.2 India Solid Tumor Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Solid Tumor Drugs Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 India Solid Tumor Drugs Market Revenues & Volume, By Radiology, 2021- 2031F |
6.2.4 India Solid Tumor Drugs Market Revenues & Volume, By Neurology, 2021- 2031F |
6.2.5 India Solid Tumor Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 India Solid Tumor Drugs Market Import-Export Trade Statistics |
7.1 India Solid Tumor Drugs Market Export to Major Countries |
7.2 India Solid Tumor Drugs Market Imports from Major Countries |
8 India Solid Tumor Drugs Market Key Performance Indicators |
8.1 Number of patients undergoing treatment for solid tumors |
8.2 Adoption rate of novel therapies for solid tumors |
8.3 Investment in research and development of solid tumor drugs |
9 India Solid Tumor Drugs Market - Opportunity Assessment |
9.1 India Solid Tumor Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Solid Tumor Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Solid Tumor Drugs Market - Competitive Landscape |
10.1 India Solid Tumor Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Solid Tumor Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here